|Other Names||Friend leukemia integration 1 transcription factor, Proto-oncogene Fli-1, Transcription factor ERGB, FLI1|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP6514a was selected from the N-term region of human FLI1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Sequence-specific transcriptional activator. Recognizes the DNA sequence 5'-C[CA]GGAAGT-3'.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
FLI1 is a sequence-specific transcriptional activator. It recognizes the DNA sequence 5'-C[CA]GGAAGT-3'.
Embree,L.J., Cancer Res. 69 (10), 4363-4371 (2009)Torlakovic,E.E., Histol. Histopathol. 23 (11), 1309-1314 (2008)Cironi,L., PLoS ONE 3 (7), E2634 (2008)
If you have any additional inquiries please email technical services at email@example.com.